CBDG (THC Farmaceuticals) ROCE %: -0.69% (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals ROCE %?

THC Farmaceuticals CBDG ROCE % is -0.69% as of Jun. 2018.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. THC Farmaceuticals's annualized ROCE % for the quarter that ended in Jun. 2018 was -0.69%.

THC Farmaceuticals  (OTCPK:CBDG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

THC Farmaceuticals ROCE % Related Terms

THC Farmaceuticals ROCE % Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals ROCE % Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
ROCE %
-2.63 -27.12 -71.03 -44.44

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.01 -0.24 0.00 -0.23 -0.69

THC Farmaceuticals ROCE % Calculation

THC Farmaceuticals's annualized ROCE % for the fiscal year that ended in Sep. 2013 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2013 )  (A: Sep. 2012 )(A: Sep. 2013 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2013 )  (A: Sep. 2012 )(A: Sep. 2013 )
=-0.02/( ( (0.052 - 0.008) + (0.049 - 0.003) )/ 2 )
=-0.02/( (0.044+0.046)/ 2 )
=-0.02/0.045
=-44.44 %

THC Farmaceuticals's ROCE % of for the quarter that ended in Jun. 2018 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2018 )  (Q: Mar. 2018 )(Q: Jun. 2018 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2018 )  (Q: Mar. 2018 )(Q: Jun. 2018 )
=-0.012/( ( (1.752 - 0.012) + (1.751 - 0.012) )/ 2 )
=-0.012/( ( 1.74 + 1.739 )/ 2 )
=-0.012/1.7395
=-0.69 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2018) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -0.69% mean?
THC Farmaceuticals (CBDG) has a ROCE % of -0.69% as of Jun. 2018.
Is THC Farmaceuticals' ROCE % too high?
THC Farmaceuticals' current ROCE % is -0.69%.
How does THC Farmaceuticals' ROCE % compare to BOXS?
THC Farmaceuticals' ROCE % of -0.69% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. THC Farmaceuticals's current ROCE % is -0.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Farmaceuticals stock overvalued right now?
THC Farmaceuticals (CBDG) has a current ROCE % of -0.69%. The current ROCE % is -0.69%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For THC Farmaceuticals (CBDG), the current ROCE % is -0.69% as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.